Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 141, Issue 4, 2018, Pages 1459-1467.e2

  Lang, Jason E ^a   Fitzpatrick, Anne M ^b   Mauger, David T ^c   Guilbert, Theresa W ^e   Jackson, Daniel J ^f   Lemanske, Robert F ^f   Martinez, Fernando D ^g   Strunk, Robert C ^h   Zeiger, Robert S ⁱ   Phipatanakul, Wanda ^k   Bacharier, Leonard B ^h   Pongracic, Jacqueline A ^l   Holguin, Fernando ^d   Cabana, Michael D ^j   Covar, Ronina A ^m   Raissy, Hengameh H ^o   Tang, Monica ^a   Szefler, Stanley J ⁿ  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BOSTON CHILDREN S HOSPITAL   (United States)

^l CHILDREN'S MEMORIAL HOSPITAL   (United States)

^m DEPARTMENT OF MEDICINE   (United States)

ⁿ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF NEW MEXICO   (United States)

more..

Author keywords

Asthma; children; exacerbation; infants; obesity; overweight

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; IBUPROFEN; PARACETAMOL; PREDNISONE; SHORT ACTING DRUG; TOBACCO SMOKE; ANTIASTHMATIC AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; BODY MASS; BODY WEIGHT; CHILD; CHILD CARE; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HISPANIC; HUMAN; MALE; MULTICENTER STUDY; OBESITY; PET ANIMAL; PRESCHOOL CHILD; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; CLINICAL TRIAL; DISEASE EXACERBATION; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BODY MASS INDEX; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; OBESITY; OVERWEIGHT;

EID: 85038632109     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.09.043     Document Type: Article

References (54)

1. Akinbami, L.J., Moorman, J.E., Bailey, C., Zahran, H.S., King, M., Johnson, C.A., et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief(94), 2012, 1–8.
2. Moorman, J.E., Akinbami, L.J., Bailey, C.M., Zahran, H.S., King, M.E., Johnson, C.A., et al. National surveillance of asthma: United States, 2001-2010. Vital Health Stat 3(35), 2012, 1–67.
3. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (Full Report 2007). Contract No.: NIH Publication No. 07-4051, 2007, NHLBI/NIH, US Department of Health and Human Services, Washington, DC.
4. Michelson, P.H., Williams, L.W., Benjamin, D.K., Barnato, A.E., Obesity, inflammation, and asthma severity in childhood: data from the National Health and Nutrition Examination Survey 2001-2004. Ann Allergy Asthma Immunol 103 (2009), 381–385.
5. Luder, E., Melnik, T.A., DiMaio, M., Association of being overweight with greater asthma symptoms in inner city black and Hispanic children. J Pediatr 132 (1998), 699–703.
6. Quinto, K.B., Zuraw, B.L., Poon, K.Y., Chen, W., Schatz, M., Christiansen, S.C., The association of obesity and asthma severity and control in children. J Allergy Clin Immunol 128 (2011), 964–969.
7. Carroll, C.L., Stoltz, P., Raykov, N., Smith, S.R., Zucker, A.R., Childhood overweight increases hospital admission rates for asthma. Pediatrics 120 (2007), 734–740.
8. Schatz, M., Zeiger, R.S., Zhang, F., Chen, W., Yang, S.J., Camargo, C.A. Jr., Overweight/obesity and risk of seasonal asthma exacerbations. J Allergy Clin Immunol Pract 1 (2013), 618–622.
9. Camargo, C.A. Jr., Boulet, L.P., Sutherland, E.R., Busse, W.W., Yancey, S.W., Emmett, A.H., et al. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J Asthma 47 (2010), 76–82.
10. Boulet, L.P., Franssen, E., Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 101 (2007), 2240–2247.
11. Forno, E., Lescher, R., Strunk, R., Weiss, S., Fuhlbrigge, A., Celedon, J.C., Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 127 (2011), 741–749.
12. Mougey, E., Lang, J.E., Allayee, H., Teague, W.G., Dozor, A.J., Wise, R.A., et al. ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma. Clin Exp Allergy 43 (2013), 512–520.
13. Peters, J.I., McKinney, J.M., Smith, B., Wood, P., Forkner, E., Galbreath, A.D., Impact of obesity in asthma: evidence from a large prospective disease management study. Ann Allergy Asthma Immunol 106 (2011), 30–35.
14. Ginde, A.A., Santillan, A.A., Clark, S., Camargo, C.A. Jr., Body mass index and acute asthma severity among children presenting to the emergency department. Pediatr Allergy Immunol 21 (2010), 480–488.
15. Lang, J.E., Hossain, M.J., Lima, J.J., Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures. J Allergy Clin Immunol 135 (2015), 886–893.e3.
16. Tantisira, K.G., Litonjua, A.A., Weiss, S.T., Fuhlbrigge, A.L., Association of body mass with pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax 58 (2003), 1036–1041.
17. van Gent, R., van der Ent, C.K., Rovers, M.M., Kimpen, J.L., van Essen-Zandvliet, L.E., de Meer, G., Excessive body weight is associated with additional loss of quality of life in children with asthma. J Allergy Clin Immunol 119 (2007), 591–596.
18. Chen, Z., Salam, M.T., Alderete, T.L., Habre, R., Bastain, T.M., Berhane, K., et al. Effects of childhood asthma on the development of obesity among school-aged children. Am J Respir Crit Care Med 195 (2017), 1181–1188.
19. Martinez, F.D., Wright, A.L., Taussig, L.M., Holberg, C.J., Halonen, M., Morgan, W.J., Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332 (1995), 133–138.
20. Bisgaard, H., Szefler, S., Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol 42 (2007), 723–728.
21. Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311 (2014), 806–814.
22. Sutherland, E.R., Camargo, C.A. Jr., Busse, W.W., Meltzer, E.O., Ortega, H.G., Yancey, S.W., et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy Asthma Proc 31 (2010), 20–25.
23. Peters-Golden, M., Swern, A., Bird, S.S., Hustad, C.M., Grant, E., Edelman, J.M., Influence of body mass index on the response to asthma controller agents. Eur Respir J 27 (2006), 495–503.
24. Guilbert, T.W., Morgan, W.J., Krawiec, M., Lemanske, R.F. Jr., Sorkness, C., Szefler, S.J., et al. The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials 25 (2004), 286–310.
25. Guilbert, T.W., Morgan, W.J., Zeiger, R.S., Mauger, D.T., Boehmer, S.J., Szefler, S.J., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354 (2006), 1985–1997.
26. Zeiger, R.S., Mauger, D., Bacharier, L.B., Guilbert, T.W., Martinez, F.D., Lemanske, R.F. Jr., et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 365 (2011), 1990–2001.
27. Fitzpatrick, A.M., Jackson, D.J., Mauger, D.T., Boehmer, S.J., Phipatanakul, W., Sheehan, W.J., et al. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol 138 (2016), 1608–1618.e12.
28. Lang, J.E., Hossain, J., Smith, K., Lima, J.J., Asthma severity, exacerbation risk, and controller treatment burden in underweight and obese children. J Asthma 49 (2012), 456–463.
29. Sheehan, W.J., Mauger, D.T., Paul, I.M., Moy, J.N., Boehmer, S.J., Szefler, S.J., et al. Acetaminophen versus ibuprofen in young children with mild persistent asthma. N Engl J Med 375 (2016), 619–630.
30. Barlow, S.E., Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120:suppl 4 (2007), S164–S192.
31. Riley, R.D., Lambert, P.C., Abo-Zaid, G., Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ, 340, 2010, c221.
32. Aragona, E., El-Magbri, E., Wang, J., Scheckelhoff, T., Scheckelhoff, T., Hyacinthe, A., et al. Impact of obesity on clinical outcomes in urban children hospitalized for status asthmaticus. Hosp Pediatr 6 (2016), 211–218.
33. Silveira, D.H., Zhang, L., Prietsch, S.O., Vecchi, A.A., Susin, L.R., Nutritional status, adiposity and asthma severity and control in children. J Paediatr Child Health 51 (2015), 1001–1006.
34. Bisgaard, H., Allen, D., Milanowski, J., Kalev, I., Willits, L., Davies, P., Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 113 (2004), e87–94.
35. Connett, G.J., Warde, C., Wooler, E., Lenney, W., Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 69 (1993), 351–355.
36. Bisgaard, H., Munck, S.L., Nielsen, J.P., Petersen, W., Ohlsson, S.V., Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 336 (1990), 649–651.
37. Gleeson, J.G., Price, J.F., Controlled trial of budesonide given by the nebuhaler in preschool children with asthma. BMJ 297 (1988), 163–166.
38. Ostrom, N.K., Decotiis, B.A., Lincourt, W.R., Edwards, L.D., Hanson, K.M., Carranza Rosenzweig, J.R., et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr 147 (2005), 213–220.
39. Zeiger, R.S., Szefler, S.J., Phillips, B.R., Schatz, M., Martinez, F.D., Chinchilli, V.M., et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117 (2006), 45–52.
40. Sorkness, C.A., Lemanske, R.F. Jr., Mauger, D.T., Boehmer, S.J., Chinchilli, V.M., Martinez, F.D., et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 119 (2007), 64–72.
41. Wang, L., Hollenbeak, C.S., Mauger, D.T., Zeiger, R.S., Paul, I.M., Sorkness, C.A., et al. Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 127 (2011), 161–166.e1.
42. Szefler, S.J., Baker, J.W., Uryniak, T., Goldman, M., Silkoff, P.E., Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 120 (2007), 1043–1050.
43. Lemanske, R.F. Jr., Mauger, D.T., Sorkness, C.A., Jackson, D.J., Boehmer, S.J., Martinez, F.D., et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 362 (2010), 975–985.
44. Szefler, S.J., Phillips, B.R., Martinez, F.D., Chinchilli, V.M., Lemanske, R.F., Strunk, R.C., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115 (2005), 233–242.
45. Ducharme, F.M., Tse, S.M., Chauhan, B., Diagnosis, management, and prognosis of preschool wheeze. Lancet 383 (2014), 1593–1604.
46. Castro-Rodriguez, J.A., Rodrigo, G.J., Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 123 (2009), e519–e525.
47. Bacharier, L.B., Guilbert, T.W., Zeiger, R.S., Strunk, R.C., Morgan, W.J., Lemanske, R.F. Jr., et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol 123 (2009), 1077–1082 e1-5.
48. Martin, R.J., Szefler, S.J., King, T.S., Kraft, M., Boushey, H.A., Chinchilli, V.M., et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119 (2007), 73–80.
49. Knuffman, J.E., Sorkness, C.A., Lemanske, R.F. Jr., Mauger, D.T., Boehmer, S.J., Martinez, F.D., et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol 123 (2009), 411–416.
50. Camargo, C.A. Jr., Sutherland, E.R., Bailey, W., Castro, M., Yancey, S.W., Emmett, A.H., et al. Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans. Curr Med Res Opin 26 (2010), 1629–1635.
51. Telenga, E.D., Tideman, S.W., Kerstjens, H.A., Hacken, N.H., Timens, W., Postma, D.S., et al. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy 67 (2012), 1060–1068.
52. Gibson, P.G., Obesity and asthma. Ann Am Thorac Soc 10:suppl (2013), S138–S142.
53. Cox, G., Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J Immunol 154 (1995), 4719–4725.
54. Fernandez-Boyanapalli, R., Goleva, E., Kolakowski, C., Min, E., Day, B., Leung, D.Y., et al. Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol 131 (2013), 1041–1047 e1-3.